Drug shortages: Study examines pandemic supply chain, HHS proposes resilience incentive
Regulatory NewsJoanne S. Eglovitch
GenericsPharmaceuticalsProduct developmentProduct LifecycleSupply Chain ManagementUnited StatesRegulatory NewsJoanne S. EglovitchGenericsPharmaceuticalsProduct developmentProduct LifecycleSupply Chain ManagementUnited States